Lexology January 23, 2020
Fenwick & West LLP

The annual gathering of life sciences executives and investors in San Francisco that many now call “JPM Week” recently concluded, marking the J.P. Morgan Healthcare Conference’s 38th year.

The Big Story of 2019 & 2020 Outlook: M&A

The one-week confab centered on the Westin St. Francis Hotel in Union Square is thought to set the stage for life sciences investing for the coming 12 months. Last year, that certainly proved to be the case when Bristol-Myers Squibb’s acquisition of Celgene—announced at the beginning of the J.P. Morgan Healthcare Conference—set the stage for a surge of M&A activity that exceeded $340 billion in value by the end of 2019.

It was the biggest year for M&A since analysts at Dealogic began...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Conferences / Podcast, Investments, Mergers & Acquisitions / JV, Pharma, Precision Medicine, Technology, Trends
Tenet Healthcare closes $975M sale of 4 hospitals to UCI Health
Chronic care access limits diagnosis & quality for women
5 most expensive, most affordable states for healthcare
HIMSS24 Why Mass General Brigham Wants to Move 10% of Patient Care to the Home
Hospitals' cash position weakens

Share This Article